News & Insights

Stay Informed With Our Latest Updates

Explore our comprehensive collection of news and in-depth insights spanning practice areas, industries, and regions.

Insights > Keyword
Insights > Type
Global > Practices
Global > Industries
Insights > Location
Insights > Person
Insights > Date Filter
4102 Results Found

Firm News June 25, 2026

Gibson Dunn Advising Serapha Bio on Merger With Boundless Bio and $230 Million Private Financing

Gibson Dunn is advising Serapha Bio, Inc. on its merger with Boundless Bio, Inc. and $230 million private financing.

Firm News May 5, 2026

Gibson Dunn Advised KKR as Lead Investor in $125 Million Series C Funding Round of Reserv

Gibson Dunn advised KKR as lead investor in the $125 million Series C funding round of Reserv Inc.

Firm News February 10, 2026

Gibson Dunn Advises Brookfield on $1.2 Billion Take-Private Acquisition of Peakstone Realty Trust

Gibson Dunn is advising Brookfield Asset Management on the $1.2 billion take-private acquisition of Peakstone Realty Trust.

Firm News August 13, 2025

Gibson Dunn Represented XOMA Royalty in Its Acquisition of LAVA Therapeutics

Gibson Dunn represented XOMA Royalty Corporation in its acquisition of clinical-stage immuno-oncology company LAVA Therapeutics N.V.

Firm News July 23, 2025

Gibson Dunn is Representing Polymarket in Its $112 Million Acquisition of QCEX

Gibson Dunn is representing Polymarket, the world's largest prediction market, in its acquisition of QCEX, a CFTC-regulated exchange and clearinghouse.

Firm News July 23, 2025

Gibson Dunn Represented XOMA Royalty in the Acquisition of ESSA Pharma by XenoTherapeutics

Gibson Dunn represented XOMA Royalty Corporation in connection with the acquisition of ESSA Pharma Inc. by XenoTherapeutics, Inc.

Firm News July 21, 2025

Gibson Dunn Advises XOMA Royalty Corporation in Connection with Acquisition of ESSA Pharma by XenoTherapeutics

Gibson Dunn represented XOMA Royalty Corporation in connection with the acquisition of ESSA Pharma Inc. (Nasdaq: EPIX) by XenoTherapeutics, Inc., …

Client Alert March 14, 2025

U.S. Cybersecurity and Data Privacy Review and Outlook – 2025

This Review addresses (1) the regulation of privacy and data security, other legislative developments, enforcement actions by federal and state …